BackPhreesia Overview
Phreesia Inc

Phreesia Target Price

Analysts' average 12-month price target for Phreesia is $12.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.94

Average Target Price

$12.1711.2% upside

6 analysts in the last 4 months

High: $16 | Low: $9

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-05-28Piper SandlerJessica Tassan$129.7% upsideOpen
2026-05-28D.A. DavidsonClark Wright$1428% upsideOpen
2026-05-28Truist FinancialJailendra Singh$129.7% upsideOpen
2026-05-28Canaccord Genuity$1646.3% upsideOpen
2026-05-20Wells FargoStan Berenshteyn$917.7% downsideOpen
2026-05-14Barclays$108.6% downsideOpen
2026-02-04Mizuho SecuritiesSteven Valiquette$22101.1% upsideOpen
2026-01-23D.A. Davidson$30174.2% upsideOpen
2026-01-08Wells FargoStan Berenshteyn$30174.2% upsideOpen
2026-01-08Truist Financial$24119.4% upsideOpen
2025-12-16Barclays$24119.4% upsideOpen
2025-12-10Truist Financial$29165.1% upsideOpen
2025-12-10Mizuho SecuritiesSteven Valiquette$28155.9% upsideOpen
2025-12-10Robert W. Baird$25128.5% upsideOpen
2025-12-09Canaccord GenuityRichard Close$33201.6% upsideOpen
2025-12-08Barclays$26137.7% upsideOpen
2025-12-02D.A. DavidsonClark Wright$35219.9% upsideOpen
2025-10-08KeyBanc$32192.5% upsideOpen
2025-09-08JMP SecuritiesAaron Kimson$34210.8% upsideOpen
2025-09-05Truist Financial$36229.1% upsideOpen
2025-09-05Raymond James$33201.6% upsideOpen
2025-09-05D.A. Davidson$33201.6% upsideOpen
2025-09-05Canaccord GenuityRichard Close$38247.3% upsideOpen
2024-12-11Robert W. BairdJoe Vruwink$30174.2% upsideOpen
2024-11-29D.A. DavidsonGil Luria$32192.5% upsideOpen
2024-09-06Truist FinancialJailendra Singh$31183.4% upsideOpen
2024-09-06Robert W. BairdJoe Vruwink$34210.8% upsideOpen
2024-09-05Piper SandlerSean Wieland$30174.2% upsideOpen
2024-05-31Canaccord GenuityRichard Close$34210.8% upsideOpen
2024-05-29Truist FinancialJailendra Singh$35219.9% upsideOpen
2024-05-24KeyBancScott Schoenhaus$30174.2% upsideOpen
2024-03-21JMP SecuritiesAaron Kimson$30174.2% upsideOpen
2024-03-18Robert W. BairdJoe Vruwink$31183.4% upsideOpen
2024-03-15RBC CapitalSean Dodge$23110.2% upsideOpen
2023-12-06NeedhamRyan MacDonald$29165.1% upsideOpen
2023-09-07StephensJeff Garro$37238.2% upsideOpen
2023-01-04NeedhamRyan MacDonald$40265.6% upsideOpen
2022-12-09RBC Capital$26137.7% upsideOpen
2022-10-12D.A. DavidsonRobert Simmons$25128.5% upsideOpen
2022-03-30Robert W. BairdJoseph Vruwink$51366.2% upsideOpen
2022-03-30Leerink PartnersStephanie Davis$29165.1% upsideOpen
2021-09-02Cantor FitzgeraldSteven Halper$70539.9% upsideOpen
2021-07-12KeyBancDonald Hooker$73567.3% upsideOpen
2021-06-08Berenberg BankGal Munda$70539.9% upsideOpen

Phreesia (PHR) FAQ

Phreesia's target price stands at $12. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $12 for PHR implies 11.2% upside versus today's price ($10.94). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Phreesia's target price evolved across reporting periods, while the comparison chart places PHR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. Phreesia's reading of $12 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.